Pelacarsen Roll-over Extension Program

Clinical trial NCT06875973 · RECRUITING

Trial details

NCT number: NCT06875973
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease

Start date: 2025-05-19
Primary completion: 2030-12-08
Enrollment: 599

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.